首页> 外文期刊>Diabetes >Niche-Dependent Regulations of Metabolic Balance in High-Fat Diet-Induced Diabetic Mice by Mesenchymal Stromal Cells
【24h】

Niche-Dependent Regulations of Metabolic Balance in High-Fat Diet-Induced Diabetic Mice by Mesenchymal Stromal Cells

机译:间质基质细胞在高脂饮食诱导的糖尿病小鼠体内代谢平衡的生态位依赖性调节。

获取原文
获取原文并翻译 | 示例
       

摘要

Mesenchymal stromal cells (MSCs) have great potential to maintain glucose homeostasis and metabolic balance. Here, we demonstrate that in mice continuously fed with high-fat diet (HFD) that developed non-insulin-dependent diabetes, two episodes of systemic MSC transplantations effectively improve glucose tolerance and blood glucose homeostasis and reduce body weight through targeting pancreas and insulin-sensitive tissues and organs via site-specific mechanisms. MSCs support pancreatic islet growth by direct differentiation into insulin-producing cells and by mitigating the cytotoxicity of interleukin 1 (IL-1) and tumor necrosis factor-α (TNF-α) in the pancreas. Localization of MSCs in the liver and skeletal muscles in diabetic animals is also enhanced and therefore improves glucose tolerance, although long-term engraftment is not observed. MSCs prevent HFD-induced fatty liver development and restore glyco-gen storage in hepatocytes. Increased expression of IL-1 receptor antagonist and Glut4 in skeletal muscles after MSC transplantation results in better blood glucose homeostasis. Intriguingly, systemic MSC transplantation does not alter adipocyte number, but it decreases HFD-induced cell infiltration in adipose tissues and reduces serum levels of adipokines, including leptin and TNF-α. Taken together, systemic MSC transplantation ameliorates HFD-induced obesity and restores metabolic balance through multisystemic regulations that are niche dependent. Such findings have supported systemic transplantation of MSCs to correct metabolic imbalance.
机译:间充质基质细胞(MSCs)具有维持葡萄糖稳态和代谢平衡的巨大潜力。在这里,我们证明,在持续喂食高脂肪饮食(HFD)的小鼠中,该小鼠发展出非胰岛素依赖型糖尿病,两次全身性MSC移植有效地改善了糖耐量和血糖稳态,并通过靶向胰腺和胰岛素-降低了体重通过特定部位的机制来敏感组织和器官。 MSC通过直接分化为产生胰岛素的细胞并减轻胰腺中白介素1(IL-1)和肿瘤坏死因子-α(TNF-α)的细胞毒性来支持胰岛的生长。尽管未观察到长期植入,但糖尿病动物肝脏和骨骼肌中MSC的定位也得到增强,因此改善了葡萄糖耐量。 MSC可防止HFD诱导的脂肪肝发育并恢复肝细胞中糖原的储存。 MSC移植后骨骼肌中IL-1受体拮抗剂和Glut4的表达增加,导致血糖稳态更高。有趣的是,全身性MSC移植不会改变脂肪细胞的数量,但会减少HFD诱导的脂肪组织中细胞的浸润并降低血清瘦素和TNF-α等脂肪因子的水平。综上所述,系统性MSC移植可通过利基依赖性的多系统调节来改善HFD诱导的肥胖症并恢复代谢平衡。这些发现支持了MSC的系统移植,以纠正代谢失衡。

著录项

  • 来源
    《Diabetes》 |2015年第3期|926-936|共11页
  • 作者单位

    Center for Stem Cell Research, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan;

    Center for Stem Cell Research, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan;

    Center for Stem Cell Research, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan;

    Department of Orthopaedic Surgery, Taipei City Hospital, Taipei, Taiwan,Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan,Stem Cell Research Center, National Yang-Ming University, Taipei, Taiwan;

    Center for Stem Cell Research, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan,Department of Ophthalmology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan,Institute of Clinical Medicine, Taipei Medical University, Taipei, Taiwan;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:46:12

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号